| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.8B | $9.4B | $9.2B | $10.6B | $2.7B | $2.2B | $2.2B | $2.4B |
| Cost of Revenue | $6.9B | $7.1B | $7.1B | $8.4B | $8.0B | $6.5B | $7.0B | $1.9B |
| Gross Profit | $1.8B | $2.3B | $2.1B | $2.1B | $0.6B | $0.5B | $0.5B | $0.5B |
| R&D Expense | $0.3B | $0.3B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $0.7B | $0.7B | $0.7B | $0.7B | $0.8B | $0.7B | $0.7B | $0.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.9B | $0.9B | $0.8B | $0.4B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $4.14 | $7.75 | $7.54 | $6.42 | $2.85 | $0.23 | $0.19 | $0.25 |
| EPS (Diluted) | $4.10 | $7.67 | $7.49 | $6.35 | $2.81 | $0.23 | $0.19 | $0.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.9B | $15.2B | $14.6B | $14.7B | $15.5B | $16.1B | $16.0B | $16.0B |
| Current Assets | $3.6B | $4.1B | $3.5B | $3.8B | $4.6B | $3.5B | $3.3B | $3.4B |
| Cash & Equivalents | $0.6B | $0.8B | $0.5B | $0.5B | $0.5B | $0.6B | $0.2B | $0.2B |
| Total Liabilities | $8.8B | $9.4B | $9.1B | $9.4B | $9.7B | $10.0B | $10.0B | $10.1B |
| Current Liabilities | $2.7B | $2.7B | $2.6B | $3.3B | $3.0B | $2.0B | $1.8B | $1.9B |
| Stockholders' Equity | $6.0B | $5.8B | $5.5B | $5.2B | $5.7B | $6.0B | $6.0B | $5.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $1.3B | $1.4B | $1.0B | $1.6B | $1.5B | $1.5B | $1.5B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.4B | $0.4B | $-0.0B | $-0.4B | $-0.5B | $-0.5B |
| Capital Expenditures | $0.5B | $0.6B | $0.8B | $0.6B | $0.6B | $0.4B | $0.4B | $0.5B |
| Financing Cash Flow | $-0.8B | $-0.5B | $-0.9B | $-1.3B | $-1.7B | $-0.7B | $-1.0B | $-1.0B |